Insider trading

Period: 120 months Stock: IONS + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

463 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

463 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

463 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

463 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
463 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
463 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

463 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
26 Dec 2023
Schneider Eugene EVP, Chf Clinical Develop Ofcr
Sold on a plan
$1.29M 25,000 at 51.46
40.9%
Planned (10b5-1)
26 Dec 2023
O'NEIL PATRICK R. EVP CLO & General Counsel
Sold on a plan
$1.07M 20,825 at 51.46
34.0%
Planned (10b5-1)
21 Dec 2023
Monia Brett P Chief Executive Officer
Sold on a plan
$862.58K 17,500 at 49.29
12.9%
Planned (10b5-1)
21 Dec 2023
BENNETT C FRANK EVP, Chief Scientific Officer
Sold on a plan
$794.21K 16,113 at 49.29
19.7%
Planned (10b5-1)
21 Dec 2023
Geary Richard S EVP, Chief Development Officer
Sold on a plan
$202.68K 4,112 at 49.29
5.3%
Planned (10b5-1)
20 Dec 2023
BENNETT C FRANK EVP, Chief Scientific Officer
Sold on a plan
$322.64K 6,500 at 49.64
9.0%
Planned (10b5-1)
20 Dec 2023
Geary Richard S EVP, Chief Development Officer
Sold on a plan
$322.64K 6,500 at 49.64
8.2%
Planned (10b5-1)
20 Dec 2023
Monia Brett P Chief Executive Officer
Sold on a plan
$322.64K 6,500 at 49.64
5.2%
Planned (10b5-1)
14 Dec 2023
Monia Brett P Chief Executive Officer
Sold on a plan 2×
$1.19M 24,000 at 49.58
16.9%
Planned (10b5-1)
14 Dec 2023
BENNETT C FRANK EVP, Chief Scientific Officer
Sold on a plan 2×
$1.12M 22,612 at 49.58
25.6%
Planned (10b5-1)
14 Dec 2023
Geary Richard S EVP, Chief Development Officer
Sold on a plan 2×
$526.24K 10,613 at 49.58
12.7%
Planned (10b5-1)
15 Nov 2023
KLEIN JOSEPH III Director
Sold on a plan
$100.00K 2,000 at 50.00
10.9%
Planned (10b5-1)
17 Oct 2023
Swayze Eric EVP Research · indirect
Sold at will
$2.49K 52 at 47.95
41.6%
Not planned
12 Oct 2023
Monia Brett P Chief Executive Officer
Sold on a plan
$173.42K 3,770 at 46.00
3.1%
Planned (10b5-1)
28 Sep 2023
BENNETT C FRANK EVP, Chief Scientific Officer
Sold on a plan
$207.39K 4,460 at 46.50
6.4%
Planned (10b5-1)
26 Sep 2023
PARSHALL B LYNNE Director
Sold on a plan
$451.27K 10,000 at 45.13
10.8%
Planned (10b5-1)
26 Sep 2023
KLEIN JOSEPH III Director
Sold on a plan
$90.25K 2,000 at 45.13
9.8%
Planned (10b5-1)
1 Aug 2023
Diaz Allene M. Director
Sold on a plan
$26.97K 657 at 41.05
4.9%
Planned (10b5-1)
18 Jul 2023
KLEIN JOSEPH III Director
Sold at will
$149.31K 3,555 at 42.00
14.9%
Not planned
7 Jul 2023
Monia Brett P Chief Executive Officer
Sold on a plan
$787.95K 18,650 at 42.25
13.3%
Planned (10b5-1)
24 May 2023
O'NEIL PATRICK R. EVP CLO & General Counsel
Sold on a plan
$63.68K 1,527 at 41.70
3.6%
Planned (10b5-1)
22 May 2023
Monia Brett P Chief Executive Officer
Sold on a plan 2×
$197.91K 4,931 at 40.14
3.4%
Planned (10b5-1)
18 Apr 2023
Baroldi Joseph EVP, Chief Business Officer
Sold at will
$141.63K 3,880 at 36.50
26.8%
Not planned
18 Apr 2023
Cadoret-Manier Onaiza EVP, Chf GL Pdt Str & Oper Ofc
Sold at will
$94.25K 2,582 at 36.50
9.6%
Not planned
18 Apr 2023
Birchler Brian EVP, Corp and Development Ops
Sold at will
$24.53K 672 at 36.50
1.8%
Not planned
6 Feb 2023
Monia Brett P Chief Executive Officer
Sold, plan not stated
$1.00M 24,651 at 40.69
14.5%
6 Feb 2023
HOUGEN ELIZABETH L EVP, Finance & CFO
Sold, plan not stated
$84.39K 2,079 at 40.59
2.7%
6 Feb 2023
O'NEIL PATRICK R. EVP CLO & General Counsel
Sold, plan not stated
$78.46K 1,920 at 40.86
4.4%
6 Feb 2023
Geary Richard S EVP, Chief Development Officer
Sold, plan not stated
$78.07K 1,920 at 40.66
2.6%
6 Feb 2023
Swayze Eric EVP Research
Sold, plan not stated
$74.03K 1,815 at 40.79
5.4%
6 Feb 2023
BENNETT C FRANK EVP, Chief Scientific Officer
Sold, plan not stated
$73.56K 1,813 at 40.57
2.5%
6 Feb 2023
Cadoret-Manier Onaiza EVP, Chf GL Pdt Str & Oper Ofc
Sold, plan not stated
$59.00K 1,451 at 40.66
6.4%
6 Feb 2023
Schneider Eugene EVP, Chf Clinical Develop Ofcr
Sold, plan not stated
$57.46K 1,413 at 40.67
5.4%
31 Jan 2023
O'NEIL PATRICK R. EVP CLO & General Counsel
Sold, plan not stated
$178.70K 4,500 at 39.71
10.2%
30 Jan 2023
O'NEIL PATRICK R. EVP CLO & General Counsel
Sold, plan not stated
$177.37K 4,500 at 39.42
9.2%
18 Jan 2023
Monia Brett P Chief Executive Officer
Sold, plan not stated
$989.95K 25,066 at 39.49
17.2%
18 Jan 2023
HOUGEN ELIZABETH L EVP, Finance & CFO
Sold, plan not stated
$328.72K 8,280 at 39.70
10.1%
18 Jan 2023
Geary Richard S EVP, Chief Development Officer
Sold, plan not stated
$311.53K 7,873 at 39.57
10.0%
18 Jan 2023
O'NEIL PATRICK R. EVP CLO & General Counsel
Sold, plan not stated
$309.48K 7,836 at 39.49
13.9%
18 Jan 2023
BENNETT C FRANK EVP, Chief Scientific Officer
Sold, plan not stated
$271.36K 6,978 at 38.89
9.3%
18 Jan 2023
Swayze Eric EVP Research
Sold, plan not stated
$223.80K 5,631 at 39.74
15.8%
18 Jan 2023
Schneider Eugene EVP, Chf Clinical Develop Ofcr
Sold, plan not stated
$188.05K 4,752 at 39.57
17.5%
18 Jan 2023
Cadoret-Manier Onaiza EVP, Chf GL Pdt Str & Oper Ofc
Sold, plan not stated
$148.22K 3,748 at 39.55
16.8%
18 Jan 2023
Baroldi Joseph EVP, Chief Business Officer · indirect
Sold, plan not stated
$14.92K 375 at 39.79
30.6%
17 Jan 2023
KLEIN JOSEPH III Director
Sold, plan not stated
$80.00K 2,000 at 40.00
10.6%
8 Sep 2022
Swayze Eric EVP Research
Sold, plan not stated
$20.49K 460 at 44.55
2.3%
5 Aug 2022
Swayze Eric EVP Research
Sold, plan not stated
$45.20 1 at 45.20
0.0%
15 Jul 2022
KLEIN JOSEPH III Director
Sold, plan not stated 2×
$50.98K 1,333 at 38.24
6.6%
21 Apr 2022
Swayze Eric EVP Research
Sold, plan not stated
$16.69K 378 at 44.15
1.8%
12 Apr 2022
O'NEIL PATRICK R. EVP CLO & General Counsel
Sold, plan not stated
$272.06K 6,792 at 40.06
16.4%
Showing 201–250 of 463. ← Newer Page 5 of 10 Older →